Ophthalmology
2022 ACTIVITY INDICATORS
- 3 public competitive led projects.
- 19 clinical led trials.
- 2 private led projects about artificial intelligence.
- 1 competitive HR contract.
- 25 publications.
- IF: 66.38
- Publications in Q1: 3 (12 %).
- 1 supervised read thesis.
- National public agency evaluators: 1 PI
- Members of editorial committees: 4 PIs.
Milestones
-
1 Success at AES22 with the award of a health project led by Dr. Arnalich entitled "Validation of tomographic imaging biomarkers as predictors of the need for keratoplasty after cataract surgery in Fuchs' corneal dystrophy: multicenter study and artificial intelligence-assisted diagnosis (PI22/01252)".
-
Private grant funded by Alcon Helathcare for the development of the study "Vitreoretinal surgery in very elderly patients: a single-center, retrospective cohort study (MWG#76035373)". PI: Julio José González López
-
García-Cruz I, Muñoz-Negrete FJ, Benito-Pascual B, Arriola-Villalobos P, Pérez-Bañón MD, Alió JL, Mingo-Botín D. Ocular findings in a Spanish cohort of myotonic dystrophy type 1. Graefes Arch Clin Exp Ophthalmol. 2023; 261(4):1109-1114. doi: 10.1007/s00417-022-05875-4. PMID: 36331602.
-
Sales-Sanz M, Huelin FJ, Ye-Zhu C, Cruz AAV, Muñoz-Negrete FJ, Rebolleda G. Müllerotomy with anterior graded Müller muscle disinsertion for Graves upper eyelid retraction: validation of surgical outcomes using Bézier curves. Graefes Arch Clin Exp Ophthalmol. 2023; 261(4):1141-1149. doi: 10.1007/s00417-022-05853-PMID: 36208307.
-
Sesmero-Garcia C, Serrador M, Revenga M, Gonzalez-Lopez JJ. An Update on the Epidemiology of Uveitis in an Urban Setting in Northern Madrid, Spain. Ocul Immunol Inflamm. 2022 Jul 6:1-6. doi: 10.1080/09273948.2022.2089900. PMID: 35793514.
Bibliometrics
ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
---|---|---|---|---|---|---|---|
2018 | 32 | 56,42 | 1,76 | 12 | 38 | 0 | 20 |
2019 | 34 | 77,38 | 2,28 | 18 | 53 | 1 | 3 |
2020 | 42 | 80,85 | 2,04 | 13 | 31 | 1 | 2 |
2021 | 41 | 86,02 | 2,10 | 13 | 32 | 1 | 2 |
2022 | 25 | 66,38 | 2,66 | 9 | 36 | 0 | 0 |
174 | 372,00 | 2,17 | 65 | 38 | 3 | 2 |
* Only original articles, editorial material, guidelines and reviews.